Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Osteoporosis

Free Subscription 20.10.2025 1 Br J Radiol 2 J Bone Miner Res 7 Osteoporos Int 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Radiol

1. CHENG X, Ma Q, Hou X, Zhao C, et al
   Diagnostic ability of spectral CT-based vertebral hydroxyapatite concentration for bone mineral density assessment in patients with liver cirrhosis: evaluating in unenhanced, arterial, and portal venous phase after intravenous contrast administration.
   Br J Radiol. 2025 Oct 13:tqaf250. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Bone Miner Res

2. MITCHELL JA, Bradfield J, McCormack SE, Chesi A, et al
   The gSOS Polygenic Score is Associated with Bone Density and Fracture Risk in Childhood.
   J Bone Miner Res. 2025 Oct 14:zjaf149. doi: 10.1093.
   PubMed         Abstract available
   
   
3. EBELING PR
   Increased Bone Fragility in Diabetes Mellitus.
   J Bone Miner Res. 2025 Oct 13:zjaf147. doi: 10.1093.
   PubMed        
   
   

   
   Osteoporos Int

4. NAYAK S, Greenspan SL
   A systematic review and meta-analysis of sequential treatment strategies for osteoporosis.
   Osteoporos Int. 2025 Oct 17. doi: 10.1007/s00198-025-07717.
   PubMed         Abstract available
   
   
5. TAKEGAMI Y, Imaizumi T, Sato K, Osawa Y, et al
   Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis.
   Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07721.
   PubMed         Abstract available
   
   
6. SEEFRIED L, Ferrari S, Pall D, Viapiana O, et al
   A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.
   Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07711.
   PubMed         Abstract available
   
   
7. KAO SW, Huang YC, Chen YC, Cheng MT, et al
   Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan.
   Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07666.
   PubMed         Abstract available
   
   
8. ADAMI G, Bartezaghi M, Montanari F, Piccinelli A, et al
   ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study.
   Osteoporos Int. 2025 Oct 13. doi: 10.1007/s00198-025-07722.
   PubMed         Abstract available
   
   
9. KWAK MK, Lee S, Lee JY, Park JW, et al
   Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study.
   Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07639.
   PubMed         Abstract available
   
   
10. SIMPSON PM, Dobson AJ, Baneshi MR, Mishra GD, et al
    Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women's Health.
    Osteoporos Int. 2025 Oct 12. doi: 10.1007/s00198-025-07710.
    PubMed         Abstract available
    
    

    
    PLoS One

11. MUHAMMAD I, Rao RS, Lee B
    BONE-Net: A novel hybrid deep-learning model for effective osteoporosis detection.
    PLoS One. 2025;20:e0334664.
    PubMed         Abstract available
    
    
12. LI Y, Xie X, Liu Y, Gong Z, et al
    Development and validation of a nomogram for all-cause mortality in osteoporosis patients over five years.
    PLoS One. 2025;20:e0334913.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.